Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings. Issue 1 (1st July 2020)

• Record Type: Journal Article
• Authors: Prabhakaran, Dorairaj; Perel, Pablo; Roy, Ambuj; Singh, Kavita; Raspail, Lana; Faria-Neto, José Rocha; Gidding, Samuel S.; Ojji, Dike; Hakim, Ferdous; Newby, L. Kristin; Stępińska, Janina; Lam, Carolyn S.P.; Jobe, Modou; Kraus, Sarah; Chuquiure-Valenzuela, Eduardo; Piñeiro, Daniel; Khaw, Kay-Tee; Bahiru, Ehete; Banerjee, Amitava; Narula, Jagat; Sliwa, Karen
• Is Part Of: Global heart. Volume 15:Issue 1(2020)
• Publication Date: 2020-07-01
• Subjects: cardiovascular disease -- coronavirus -- COVID-19 -- low resource settings -- low income countries -- middle income countries; Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; Cardiovascular system -- Diseases -- Prevention -- Periodicals; Cardiovascular system -- Diseases -- Treatment -- Periodicals; Cardiovascular system -- Diseases -- Prevention; Cardiovascular Diseases -- prevention & control -- Periodicals; Cardiovascular Diseases -- Periodicals; Developing Countries -- Periodicals; Electronic journals; Electronic journals; Periodicals; 616.1005
• DOI: 10.5334/gh.823
• Languages: English
• ISSNs: 2211-8160

Abstract

In this paper, we provide recommendations on the management of cardiovascular disease (CVD) among patients with confirmed or suspected coronavirus disease (COVID-19) to facilitate the decision making of healthcare professionals in low resource settings. The emergence of novel coronavirus disease, also known as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), has presented an unprecedented global challenge for the healthcare community. The ability of SARS-CoV-2 to get transmitted during the asymptomatic phase and its high infectivity have led to the rapid transmission of COVID-19 beyond geographic regions, leading to a pandemic. There is concern that COVID-19 is cardiotropic, and it interacts with the cardiovascular system on multiple levels. Individuals with established CVD are more susceptible to severe COVID-19. Through a consensus approach involving an international group this WHF statement summarizes the links between cardiovascular disease and COVID-19 and present some practical recommendations for the management of hypertension and diabetes, acute coronary syndrome, heart failure, rheumatic heart disease, Chagas disease, and myocardial injury for patients with COVID-19 in low-resource settings. This document is not a clinical guideline and it is not intended to replace national clinical guidelines or recommendations. Given the rapidly growing burden posed by COVID-19 illness and the associated severe prognostic implication of CVD involvement, further research is required to understand the potential mechanisms linking COVID-19 and CVD, clinical presentation, and outcomes of various cardiovascular manifestations in COVID-19 patients.